Curaleaf International operates across all stages of supply chain for medical cannabis, from cultivation to patient care.
Curaleaf International boasts a comprehensive network spanning Europe, Canada and Australasia, ensuring robust operations across the medical cannabis supply chain. In the United Kingdom, the infrastructure includes Curaleaf Clinic, a dispensing pharmacy, and a state-of-the-art laboratory.
In Portugal, they operate advanced cultivation and processing facilities that adhere to rigorous Good Manufacturing Practice (EU-GMP) standards. Spain is home to another key site, focusing on EU-GMP processing, meticulous quality assurance, and cutting-edge research.
Distribution in Germany is conducted by Four20 Pharma, a leading wholesaler and distributor. In Poland, Curaleaf International’s presence includes both a wholesaler and a clinic, expanding access to patients. Rounding the CUraleaf International family of businesses is Northern Green Canada, a trusted EU-GMP producer.
